M&A Deal Summary

AUCTUS Capital Partners AG Acquires PharmaLex

On October 14, 2015, private equity firm AUCTUS Capital Partners AG acquired life science company PharmaLex

Acquisition Highlights
  • This is AUCTUS Capital Partners AG’s 2nd transaction in the Life Science sector.
  • This is AUCTUS Capital Partners AG’s 27th transaction in Germany.
Investment Fate
  • PharmaLex was sold to a publicly-traded strategic buyer in 2022 for 1.3B USD.

M&A Deal Summary
Date 2015-10-14
Target PharmaLex
Sector Life Science
Buyer(s) AUCTUS Capital Partners AG
Deal Type Consolidation

Target

PharmaLex

Frankfurt, Germany
website
PharmaLex is a provider of solutions for drug development, regulatory affairs, and pharmacovigilance. The company features a multidisciplinary team from more than 40 nationalities with knowledge that spans the whole spectrum of life sciences, including biology, biochemistry, pharmacology, engineering, food chemistry, medicine, nutritional science, pharmacy science, toxicology, and veterinary medicine. PharmaLex is based in Frankfurt, Germany.

Search 192,349 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

AUCTUS Capital Partners AG

Munich, Germany

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 2001
PE ASSETS 500M EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

AUCTUS Capital Partners AG targets small-cap and mid-market opportunities in German-speaking countries (primarily Germany, Switzerland and Austria). The Firm focuses on 'sustainable' companies operating in fragmented sectors with strong market positions and growth potential. AUCUTS generally looks to invest in companies valued between €10 and €100 million with revenues of €10 to €150 million. Areas of interest include healthcare, automotive, fine chemicals/pharma, IT/software, education, and business services. The Firm will consider a variety of transaction types including buy-and-build, MBOs, MBIs, and spin-offs/carve-outs. AUCTUS Capital Partners AG was formed in 2001 and is based in Munich.

DEAL STATS #
Overall 30 of 47
Sector (Life Science) 2 of 2
Type (Consolidation) 1 of 1
Country (Germany) 27 of 39
Year (2015) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-14 YES Pharmaceutical Development Services

Friedrichsdorf, Germany

YES Pharmaceutical Development Services GmbH is a highly specialized service provider in the fields of regulatory affairs, product development and drug safety for pharmaceuticals, medical devices, and cosmetics.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-11 Career Partner

Munich, Germany

Career Partner GmbH is a provider of private education and personnel development. CPG offers academic state-approved study programs, certified trainings, and innovative continuous education programs for experts and managers of all industries. CPG is one of the largest e-learning providers in Germany offering a multitude of courses, distance learning modules, company-specific solutions, and services in the field of digital learning.

Sell €107M
Mergr

Product

Company

Legal